Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1985 Apr;40(4):272–277. doi: 10.1136/thx.40.4.272

Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients.

K Osterlind, M Hansen, H H Hansen, P Dombernowsky, M Rørth
PMCID: PMC460045  PMID: 2992111

Abstract

A therapeutic policy of surgery in the treatment of small cell carcinoma of the lung was evaluated in a retrospective series of 874 consecutive patients. All patients were included in one of six clinical trials of intensive combination chemotherapy and radiotherapy, carried out during 1973-81. General criteria of resectability, including normal appearances at mediastinoscopy, were fulfilled in 33 electively operated patients and in 46 non-operated patients. An elective operation was defined as a thoracotomy performed with the intention of pulmonary resection in a patient known to have small cell carcinoma. Pneumonectomy or lobectomy was performed in 73% of the electively operated patients. Residual macroscopic or microscopic tumour tissue was left after half of these resections. Both operated patients and non-operated patients with operable tumours survived significantly longer than 696 patients deemed to have been inoperable. There was no significant difference, however, in the duration of survival between the two subsets of operable patients. According to this analysis, a treatment policy of surgery for resectable small cell carcinoma does not lead to better overall results than treatment with chemotherapy and radiotherapy alone.

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GOLDMAN K. P. HISTOLOGY OF LUNG CANCER IN RELATION TO PROGNOSIS. Thorax. 1965 Jul;20:298–302. doi: 10.1136/thx.20.4.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hansen H. H., Dombernowsky P., Hansen M., Hirsch F. Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination. Ann Intern Med. 1978 Aug;89(2):177–181. doi: 10.7326/0003-4819-89-2-177. [DOI] [PubMed] [Google Scholar]
  3. Hansen H. H., Dombernowsky P., Hirsch F. R., Hansen M., Rygård J. Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer. 1980 Jul 15;46(2):279–284. doi: 10.1002/1097-0142(19800715)46:2<279::aid-cncr2820460210>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  4. Hansen H. H., Hansen M., Rørth M., Dombernowsky P. Small-cell carcinoma of the bronchus. Lancet. 1980 Feb 23;1(8165):416–416. doi: 10.1016/s0140-6736(80)90959-9. [DOI] [PubMed] [Google Scholar]
  5. Lennox S. C., Flavell G., Pollock D. J., Thompson V. C., Wilkins J. L. Results of resection for oat-cell carcinoma of the lung. Lancet. 1968 Nov 2;2(7575):925–927. doi: 10.1016/s0140-6736(68)91163-x. [DOI] [PubMed] [Google Scholar]
  6. Martini N., Wittes R. E., Hilaris B. S., Hajdu S. I., Beattie E. J., Jr, Golbey R. B. Oat cell carcinoma of the lung. Clin Bull. 1975;5(4):144–148. [PubMed] [Google Scholar]
  7. Meyer J. A., Comis R. L., Ginsberg S. J., Ikins P. M., Burke W. A., King G. A., Gullo J. J., DiFino S. M., Tinsley R. W., Parker F. B., Jr Phase II trial of extended indications for resection is small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1982 Jan;83(1):12–19. [PubMed] [Google Scholar]
  8. Mountain C. F., Carr D. T., Anderson W. A. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):130–138. doi: 10.2214/ajr.120.1.130. [DOI] [PubMed] [Google Scholar]
  9. Oldham R. K., Greco F. A. Small-cell carcinoma of the bronchus. Lancet. 1980 Mar 1;1(8166):478–478. doi: 10.1016/s0140-6736(80)91013-2. [DOI] [PubMed] [Google Scholar]
  10. Osterlind K., Sörenson S., Hansen H. H., Dombernowsky P., Hirsch F. R., Hansen M., Rørth M. Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung. Cancer Res. 1983 Dec;43(12 Pt 1):6085–6089. [PubMed] [Google Scholar]
  11. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shields T. W., Higgins G. A., Jr, Matthews M. J., Keehn R. J. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1982 Oct;84(4):481–488. [PubMed] [Google Scholar]
  13. Shore D. F., Paneth M. Survival after resection of small cell carcinoma of the bronchus. Thorax. 1980 Nov;35(11):819–822. doi: 10.1136/thx.35.11.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. TAYLOR A. B., SHINTON N. K., WATERHOUSE J. A. Histology of bronchial carcinoma in relation to prognosis. Thorax. 1963 Jun;18:178–181. doi: 10.1136/thx.18.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WATSON W. L., BERG J. W. Oat cell lung cancer. Cancer. 1962 Jul-Aug;15:759–768. doi: 10.1002/1097-0142(196207/08)15:4<759::aid-cncr2820150410>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES